Guangzhou good Biotechnology Co., Ltd. was founded in December 2009, the registered capital of 30 million yuan, is a commitment to research and development, production and sales of the world's leading new gene molecular diagnostic system of high-tech enterprises. The company is in High tech enterprises, Zhongguancun high-tech enterprises, sea fan enterprise, 2013 was named & ldquo; the most growth potential of students start-ups & rdquo; Zhongguancun national independent demonstration area & ldquo; seed engineering & rdquo; the third batch of & ldquo; gold Seed enterprise ”.

Good idea is “ let everyone benefit from the molecular diagnosis of ”. So far, good to have a drop of blood rapid nucleic acid detection system field only global, the platform technology allows the community grassroots medical institutions: Health screening can also achieve accurate, will bring great contribution to the popularization of major infectious diseases prevention and control in our country, the cancer screening, personalized medicine.